XRG Price sensitive 22 Apr 2025, 9:28 AM

Quarterly Activities Report and Appendix 4C - 31 Mar 25

Xreality Group Ltd

xReality Group Ltd Reports Strong Quarterly Results

Key points

  • Another strong quarter for cash receipts and new sales of Operator XR in the US
  • Increase in Annual Recurring Revenue (ARR) and Total Contract Value (TCV)
  • Balance Sheet Restructure complete with 48% debt reduction

Full summary

xReality Group Limited (ASX:XRG) has reported a strong Q3 FY25, with cash receipts of $3.4m ($13.0m YTD) driven by continued growth in its Operator XR enterprise software and entertainment businesses. Operator XR saw $1.5m in sales for the quarter ($6.3m YTD), while the entertainment division generated $1.9m ($6.6m YTD). The company's Annual Recurring Revenue (ARR) increased 17% quarter-on-quarter to $4.2m, and Total Contract Value (TCV) grew 24% to $9.2m YTD, up 124% on FY24. The company also completed a balance sheet restructure, reducing total debt by 48% through the conversion of $4.6m of subordinate debt and a new $6m senior debt facility. Additionally, xReality established an AI advisory board and entered a strategic research collaboration with the Advanced Law Enforcement Rapid Response Training (ALERRT) Centre to optimize Operator XR's technology platform. The outlook remains positive, with 280 qualified and active sales opportunities and a $29.3m total sales pipeline.

Guidance

The company expects continued growth in its Operator XR enterprise software business, with Annual Recurring Revenue (ARR) of $4.2m as of Q3 FY25 and a Total Contract Value (TCV) of $9.2m YTD, up 124% on FY24.

Outlook

The outlook remains positive, with 280 qualified and active sales opportunities and a $29.3m total sales pipeline. The company is also focused on accelerating AI implementation and securing its competitive edge in military and law enforcement training through its newly established AI advisory board and strategic research collaboration.

Summary generated by a large language model. Please interpret with care.

Sign in for more about this company, including guidance changes and other insights.
Sign in